@article{article, title  = {{Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.}},

 url = {{}},

 year = {{2014}},

 month = {{4}},

 author = {{Corrie PG and Marshall A and Dunn JA and Middleton MR and Nathan PD and Gore M and Davidson N and Nicholson S and Kelly CG and Marples M and Danson SJ et al}},

 doi = {{10.1016/S1470-2045(14)70110-X}},

 volume = {{15}},

 journal = {{Lancet Oncol}},

 issue = {{6}},

 pages = {{620-630}},

 note = {{Accessed on 2025/01/03}}}